Analysts Offer Insights on Healthcare Companies: Talkspace (TALK) and Insmed (INSM)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Talkspace (TALK – Research Report) and Insmed (INSM – Research Report) with bullish sentiments.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Talkspace (TALK)
In a report released today, Ryan MacDonald from Needham reiterated a Buy rating on Talkspace, with a price target of $6.00. The company’s shares closed last Thursday at $4.83.
According to TipRanks.com, MacDonald ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Talkspace has an analyst consensus of Strong Buy, with a price target consensus of $5.20, representing a 14.3% upside. In a report issued on February 5, Canaccord Genuity also maintained a Buy rating on the stock with a $6.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Insmed (INSM)
Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Insmed today and set a price target of $205.00. The company’s shares closed last Thursday at $158.71.
According to TipRanks.com, Willey is a 4-star analyst with an average return of
Insmed has an analyst consensus of Strong Buy, with a price target consensus of $218.88, a 42.3% upside from current levels. In a report issued on February 6, Evercore ISI also maintained a Buy rating on the stock with a $208.00 price target.
